10/14/2021 | Press release | Distributed by Public on 10/14/2021 01:12
Sandoz is a company duly registered in accordance with the laws of the Canton of Basil of Switzerland. Sandoz a Novartis AG division (hereafter 'Novartis') which is active in the manufacturing of generic pharmaceuticals and biosimilars mainly in the generic antibiotics and oncology medicines.
Novartis is company based in Switzerland and is active globally in the health care industry and the distribution and trade of medical products.
The Target is the cephalosporin antibiotics business of GlaxoSmithKline. The Target includes the established brands global rights to three established brands Zinnat®, Zinacef® and Fortum® of GSK and the related agreements with customers, suppliers and intellectual property rights, distribution licences and business records.